Questions and answers on implementation of risk based prevention of cross contamination in production and ‘Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities’ (EMA/CHMP/CVMP/SWP/169430/2012)

  • Email
  • Help

Document details

Download document Questions and answers on implementation of risk based prevention of cross contamination in production and ‘Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities’ (EMA/CHMP/CVMP/SWP/169430/2012)
Reference number EMA/CHMP/CVMP/SWP/463311/2016
Status draft: consultation open
First published 2017-01-09
Last updated 2017-01-09
Consultation start date 2017-01-09
Consultation end date 2017-04-30
Email address for submissions adm-gmdp@ema.europa.eu